Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Operating Margin 2011-2025 | ZTS

Current and historical operating margin for Zoetis (ZTS) over the last 10 years. The current operating profit margin for Zoetis as of March 31, 2025 is 29.30%.
  
Zoetis Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $9.29B $3.20B 34.42%
2024-12-31 $9.26B $3.13B 33.85%
2024-09-30 $9.15B $3.05B 33.34%
2024-06-30 $8.92B $2.89B 32.46%
2024-03-31 $8.73B $2.99B 34.19%
2023-12-31 $8.54B $2.94B 34.36%
2023-09-30 $8.37B $2.88B 34.38%
2023-06-30 $8.22B $2.83B 34.40%
2023-03-31 $8.09B $2.63B 32.44%
2022-12-31 $8.08B $2.66B 32.87%
2022-09-30 $8.01B $2.57B 32.10%
2022-06-30 $8.00B $2.56B 32.05%
2022-03-31 $7.89B $2.53B 32.04%
2021-12-31 $7.78B $2.49B 32.00%
2021-09-30 $7.62B $2.40B 31.54%
2021-06-30 $7.41B $2.34B 31.57%
2021-03-31 $7.01B $2.19B 31.18%
2020-12-31 $6.68B $2.00B 29.90%
2020-09-30 $6.54B $2.01B 30.77%
2020-06-30 $6.34B $1.94B 30.66%
2020-03-31 $6.34B $1.92B 30.24%
2019-12-31 $6.26B $1.80B 28.77%
2019-09-30 $6.15B $1.78B 28.98%
2019-06-30 $6.05B $1.67B 27.65%
2019-03-31 $5.91B $1.65B 27.97%
2018-12-31 $5.83B $1.69B 29.01%
2018-09-30 $5.72B $1.70B 29.75%
2018-06-30 $5.59B $1.70B 30.37%
2018-03-31 $5.44B $1.61B 29.49%
2017-12-31 $5.31B $1.53B 28.74%
2017-09-30 $5.12B $1.33B 25.88%
2017-06-30 $5.02B $1.25B 24.83%
2017-03-31 $4.96B $1.23B 24.87%
2016-12-31 $4.89B $1.23B 25.12%
2016-09-30 $4.89B $1.07B 21.82%
2016-06-30 $4.86B $1.01B 20.71%
2016-03-31 $4.83B $0.65B 13.41%
2015-12-31 $4.77B $0.55B 11.44%
2015-09-30 $4.81B $0.63B 13.12%
2015-06-30 $4.81B $0.60B 12.40%
2015-03-31 $4.79B $0.82B 17.18%
2014-12-31 $4.79B $0.82B 17.14%
2014-09-30 $4.72B $0.79B 16.76%
2014-06-30 $4.61B $0.74B 16.00%
2014-03-31 $4.57B $0.73B 15.87%
2013-12-31 $4.56B $0.69B 15.13%
2013-09-30 $4.48B $0.65B 14.41%
2013-06-30 $4.40B $0.67B 15.32%
2013-03-31 $4.38B $0.74B 16.88%
2012-12-31 $4.34B $0.72B 16.56%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $68.989B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.582B 28.73
Takeda Pharmaceutical (TAK) Japan $46.711B 9.29
Daiichi Sankyo, - (DSNKY) Japan $41.733B 21.39
BeOne Medicines - (ONC) Cayman Islands $27.433B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.614B 0.00
Summit Therapeutics (SMMT) United States $18.567B 0.00
Merck (MKKGY) Germany $17.150B 12.57
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.330B 11.79
Neurocrine Biosciences (NBIX) United States $13.208B 45.24
Orion OYJ (ORINY) Finland $11.038B 29.85
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.635B 46.69
Corcept Therapeutics (CORT) United States $7.623B 61.97
Madrigal Pharmaceuticals (MDGL) United States $7.004B 0.00
Grifols, S.A (GRFS) Spain $6.697B 0.00
Ionis Pharmaceuticals (IONS) United States $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.068B 15.41
Soleno Therapeutics (SLNO) United States $4.110B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.990B 0.00
Hypermarcas (HYPMY) Brazil $2.988B 19.65
Catalyst Pharmaceuticals (CPRX) United States $2.660B 9.32
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.611B 14.12
NewAmsterdam Pharma (NAMS) Netherlands $2.418B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.927B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.833B 0.00
Ocular Therapeutix (OCUL) United States $1.757B 0.00
ARS Pharmaceuticals (SPRY) United States $1.737B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.445B 0.00
ProKidney (PROK) United States $1.329B 0.00
Guardian Pharmacy Services (GRDN) United States $1.291B 0.00
Harrow (HROW) United States $1.281B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.189B 23.78
Enliven Therapeutics (ELVN) United States $1.102B 0.00
Ardelyx (ARDX) United States $1.074B 0.00
Collegium Pharmaceutical (COLL) United States $1.045B 5.64
Akebia Therapeutics (AKBA) United States $1.032B 0.00
Verve Therapeutics (VERV) United States $0.983B 0.00
Dyne Therapeutics (DYN) United States $0.982B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.930B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.799B 0.00
KalVista Pharmaceuticals (KALV) United States $0.722B 0.00
Zevra Therapeutics (ZVRA) United States $0.685B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.685B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.617B 0.00
USANA Health Sciences (USNA) United States $0.614B 13.36
Bioventus (BVS) United States $0.573B 14.52
Theravance Biopharma (TBPH) United States $0.565B 0.00
Elite Pharmaceuticals (ELTP) United States $0.554B 0.00
Organogenesis (ORGO) United States $0.545B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.484B 10.10
Tourmaline Bio (TRML) United States $0.462B 0.00
Savara (SVRA) United States $0.413B 0.00
Aquestive Therapeutics (AQST) United States $0.398B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 9.12
Altimmune (ALT) United States $0.336B 0.00
Heron Therapeutics (HRTX) United States $0.333B 0.00
Nektar Therapeutics (NKTR) United States $0.310B 0.00
AleAnna (ANNA) United States $0.310B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 26.47
Aldeyra Therapeutics (ALDX) United States $0.279B 0.00
OmniAb (OABI) United States $0.248B 0.00
Nanobiotix S.A (NBTX) France $0.244B 0.00
Esperion Therapeutics (ESPR) United States $0.236B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
China SXT Pharmaceuticals (SXTC) China $0.203B 0.00
4D Molecular Therapeutics (FDMT) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Liminatus Pharma (LIMN) United States $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Galectin Therapeutics (GALT) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.151B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.122B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.112B 18.41
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Vivani Medical (VANI) United States $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Achieve Life Sciences (ACHV) Canada $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Jupiter Neurosciences (JUNS) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Rafael Holdings (RFL) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Klotho Neurosciences (KLTO) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
PMV Pharmaceuticals (PMVP) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 33.33
Mural Oncology (MURA) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Vivos Therapeutics (VVOS) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
BioVie (BIVI) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.05
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.05
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00